FDA Inspection
Pentagon Blood Collection SitePentagon Blood Collection Site – FDA Inspection, Aug 22, 2019
Record Details
This FDA Inspection record concerns Pentagon Blood Collection Site, with an inspection on August 22, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · fafef7b1-f618-46eb-814d-ba78a45ae756
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1100722
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 640.21(f)Deferral due to rbc loss
- 21 CFR 630.10(g)(1)Proof Of Identity
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pentagon Blood Collection Site
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 3, 2025 | Not classified | Baltimore District Office | |
| July 18, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 28, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 29, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 29, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Pentagon Blood Collection Site
- FDA Inspection 1281608 - 2025-09-03
- FDA Inspection 1211521 - 2023-07-18
- FDA Inspection 1022639 - 2017-07-28
- FDA Inspection 936889 - 2015-07-29
- FDA Inspection 893225 - 2014-08-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.